Tonix Pharm Hldg (TNXP) Posts Q1 Loss of 59c/Share

Tonix Pharm Hldg (NASDAQ: TNXP) reported Q1 EPS of ($0.59), $0.24 worse than the analyst estimate of ($0.35).

For earnings history and earnings-related data on Tonix Pharm Hldg (TNXP) click here.

You May Also Be Interested In

• Jefferies upgrades Five Below to Buy, sees path to TJX-like re-rating
• Azitra, Inc. (AZTR) Tops Q2 EPS by 54c
• Wolfe Research upgrades Biogen, AbbVie on pipeline strength and valuation